| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_545917c7384f2a993d6047c35ea366a3 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-7028
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-78 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57419
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57438
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6842
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57473 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate |
2020-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1fe47b36c8492cd5c6019d66b5cd4979
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9fdbc0094f9738f99ccd73bd965541b7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_251f965a0ac3536ea3b2e0ffdb67c709 |
| publicationDate |
2022-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2022283163-A1 |
| titleOfInvention |
Biomarkers for Detecting Secondary Liver Cancer |
| abstract |
The invention relates to a method for typing a subject for the presence or absence of a secondary liver cancer, comprising the steps of—measuring in a sample comprising peptides from a subject a peptide level for (i) a peptide comprising the amino acid sequence of SEQ ID NO:4 or a peptide comprising an amino acid sequence that has at least 90% sequence identity to the amino acid sequence of SEQ ID NO:4; and/or (ii) a peptide comprising the amino acid sequence of SEQ ID NO:1 or a peptide comprising an amino acid sequence that has at least 90% sequence identity to the amino acid sequence of SEQ ID NO:1; and—typing said subject for the presence or absence of said secondary liver cancer on the basis of the measured peptide level. |
| priorityDate |
2019-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |